MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1245/s10434-022-11758-z

Медицинская библиотека · Annals of surgical oncology · 2022

Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II).

Jakub James W, Lowe Michael, Howard J Harrison, Farma Jeffrey M, Sarnaik Amod, Tuttle Todd, Neuman Heather B, Ariyan Charlotte E, Uppal Abhineet, Trocha Steve, Beasley Georgia M, Wasif Nabil, Bilimoria Karl Y, Thomay Alan A, Allred Jacob B, Chen Lucia, Terando Alicia M, Wayne Jeffrey D, Thompson John F, Cochran Alistair J, Sim Myung-Shin, Elashoff David E, Delman Keith A, Faries Mark B

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Minimally invasive inguinal lymphadenectomy (MILND) is safe and feasible, but limited data exist regarding oncologic outcomes.

METHODS

This study performed a multi-institutional retrospective cohort analysis of consecutive MILND performed for melanoma between January 2009 and June 2016. The open ILND (OILND) comparative cohort comprised patients enrolled in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II) between December 2004 and March 2014.The pre-defined primary end point was the same-basin regional nodal recurrence, calculated using properties of binomial distribution. Time to events was calculated using the Kaplan-Meier method. The secondary end points were overall survival, progression-free survival, melanoma-specific survival (MSS), and distant metastasis-free survival (DMFS).

RESULTS

For all the patients undergoing MILND, the same-basin regional recurrence rate was 4.4 % (10/228; 95 % confidence interval [CI], 2.1-7.9 %): 8.2 % (4/49) for clinical nodal disease and 3.4 % (6/179) for patients with a positive sentinel lymph node (SLN) as the indication. For the 288 patients enrolled in MSLT-II who underwent OILND for a positive SLN, 17 (5.9 %) had regional node recurrence as their first event. After controlling for ulceration, positive LN count and positive non-SLNs at the time of lymphadenectomy, no difference in OS, PFS, MSS or DMFS was observed for patients with a positive SLN who underwent MILND versus OILND.

CONCLUSION

This large multi-institutional experience supports the oncologic safety of MILND for melanoma. The outcomes in this large multi-institutional experience of MILND compared favorably with those for an OILND population during similar periods, supporting the oncologic safety of MILND for melanoma.

Для цитирования: Jakub James W, Lowe Michael, Howard J Harrison, Farma Jeffrey M, Sarnaik Amod, Tuttle Todd, Neuman Heather B, Ariyan Charlotte E, Uppal Abhineet, Trocha Steve, Beasley Georgia M, Wasif Nabil, Bilimoria Karl Y, Thomay Alan A, Allred Jacob B, Chen Lucia, Terando Alicia M, Wayne Jeffrey D, Thompson John F, Cochran Alistair J, Sim Myung-Shin, Elashoff David E, Delman Keith A, Faries Mark B. Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II).. Annals of surgical oncology. 2022. DOI: 10.1245/s10434-022-11758-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.